News about Market

Jacobio Pharma Signs Global Licensing Deal with AstraZeneca for Pan-KRAS Drug

Under the agreement, Jacobio will receive USD 100 million upfront and is eligible for up to USD 1.915 billion in development and commercial milestones, along with tiered royalties on ex-China sales, while AstraZeneca will lead all ex-China development, regulatory and commercial activities for JAB-23E73.

Market | 22/12/2025 | By News Bureau |  195

IN8bio Prices Private Placement of up to USD 40.2 Million

IN8bio has priced a private placement of up to USD 40.2 million, comprising USD 20.1 million upfront and a milestone-based additional USD 20.1 million, to advance its novel gamma-delta T cell engager INB-619 towards an IND application, extend its cash runway into the first half of 2027.

Market | 20/12/2025 | By News Bureau |  164

Symbiotec Pharmalab Files Draft Papers to Raise INR 2,180 Crore via IPO

Symbiotec Pharmalab Ltd has filed draft red herring prospectus papers with the Securities and Exchange Board of India to raise INR 2,180 crore through an initial public offering.

Market | 20/12/2025 | By Darshana |  219

Cue Biopharma Prices USD 10 Million Public Offering

Cue Biopharma has priced a USD 10 million public offering, with gross proceeds expected to be approximately USD 10 million before underwriting discounts, commissions, and other offering-related expenses.

Market | 20/12/2025 | By News Bureau |  140

Ambros Therapeutics Launches with USD 125 Million Series A to Advance CRPS Therapy

Ambros Therapeutics has launched with a USD 125 million Series A financing to advance neridronate for Complex Regional Pain Syndrome Type 1, supported by multiple FDA designations and an oversubscribed round led by RA Capital Management and Patient Square Capital, with a pivotal phase III trial planned for early 2026.

Market | 19/12/2025 | By News Bureau |  389

Takeda Becomes a BaseLaunch Partner

BaseLaunch has added Takeda as a new pharmaceutical partner to its biotech venture incubator, expanding its network of global pharma backers supporting and funding early-stage drug development startups.

Market | 19/12/2025 | By News Bureau |  125

Zydus Lifesciences Inks Exclusive Deal with Myriad Genetics for Cancer Risk Tests in India

Zydus Lifesciences has entered into an exclusive agreement with US-based Myriad Genetics to introduce clinically validated cancer-risk assessment diagnostic tests in India, aimed at enabling personalised, evidence-based cancer care and strengthening early detection and preventive oncology efforts in the country.

Market | 19/12/2025 | By News Bureau |  152

Pfizer and Cipla Form Exclusive Marketing Partnership for Select Brands in India

Pfizer and Cipla have joined forces in an exclusive marketing and distribution agreement for select brands in India. The collaboration aims to improve access and availability of these key medicines, ensuring patients across the country benefit from a wider reach and streamlined supply.

Market | 19/12/2025 | By News Bureau |  194

Lupin Inks Exclusive Licensing Deal with Neopharmed for Plasil in Brazil and Philippines

Global pharmaceutical major Lupin Limited said its subsidiaries in the Philippines, Multicare Pharmaceuticals, and in Brazil, MedQuimica, have entered into an exclusive licensing agreement with Italy-based Neopharmed Gentili S.p.A. to market and promote the gastroenterology brand Plasil (metoclopramide) in their respective markets.

Market | 19/12/2025 | By Darshana |  297

Nona Biosciences and Valink Partner to Advance Biologics Discovery

Nona Biosciences and Valink Therapeutics have partnered to advance biologics discovery by combining Nona’s Harbour Mice fully human antibody technologies, including heavy chain-only antibodies, with Valink’s LiliumX discovery platform to generate and screen thousands of novel drug candidates.

Market | 18/12/2025 | By News Bureau |  121